Search

Your search keyword '"Attaleb, Mohammed"' showing total 128 results
Start Over Author "Attaleb, Mohammed"
128 results on '"Attaleb, Mohammed"'

9. Synthesis and genotoxic evaluation of a 4-(Oxiran-2-ylmethyl)-1,4-benzothiazin-3-one

Author

Hassan Jaddi, Ahmed Moussaif, Laila. Benbacer, Attaleb Mohammed, Ellouz Mohamed, Nada Kheira Sebbar, Abdelkarim Filali Maltouf, El Mokhtar Essassi, and El Mzibri Mohammed

Subjects
Pharmacology (medical), Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Abstract

A new benzothiazine: 4-(oxiran-2-ylmethyl)-1,4-benzothiazin-3-one was synthesized by a liquid-solid phase transfer catalysis reaction. The new compound was well characterized by FT-IR spectroscopy, the nuclear resonance of proton and carbon 13, and mass spectrometry. The genotoxicity of the new benzothiazine derivative was assessed using the micronucleus assay on Chinese Hamster Ovary cells (CHO cells), as compared to its cytotoxicity against CHO cells. Accordingly, the chromosomal damages were detected with micronucleus frequency (MN) and cytotoxicity was assessed with cyto-blocking proliferation index (CBPI). The newly synthesized benzothiazine derivative was not cytotoxic and don't exhibit, in absence of metabolic activation, any genotoxic effect, making it a potential chemical for further biological explorations and an interesting scaffold for new derivatives.

Published
2022
Full Text
View/download PDF

10. The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer

Author

El Azzouzi, Meryem, primary, El Ahanidi, Hajar, additional, Hafidi Alaoui, Chaimae, additional, Chaoui, Imane, additional, Benbacer, Laila, additional, Tetou, Mohammed, additional, Hassan, Ilias, additional, Bensaid, Mounia, additional, Oukabli, Mohamed, additional, Ameur, Ahmed, additional, Al Bouzidi, Abderrahmane, additional, Attaleb, Mohammed, additional, and El Mzibri, Mohammed, additional

Published
2023
Full Text
View/download PDF

12. Association between single nucleotide polymorphisms in DNA repair genes and the efficacy of radiotherapy in nasopharyngeal carcinoma patients

Author

Benzeid, Rajaa, primary, Gihbid, Amin, additional, Tawfik, Nezha, additional, Benchakroun, Nadia, additional, Bendahhou, Karima, additional, Benider, Abdellatif, additional, Guensi, Amal, additional, Benna, Naima El, additional, Maltouf, Abdelkarim Filali, additional, El Mzibri, Mohammed, additional, Attaleb, Mohammed, additional, Khyatti, Meriem, additional, and Chaoui, Imane, additional

Published
2023
Full Text
View/download PDF

13. Genetic Polymorphisms in ERCC1 Gene and Their Association with Response to Radiotherapy in Moroccan Patients with Nasopharyngeal Carcinoma

Author

Benzeid, Rajaa, primary, Gihbid, Amina, additional, Tawfiq, Nezha, additional, Benchakroun, Nadia, additional, Bendahhou, Karima, additional, Benider, Abdelatif, additional, Guensi, Amal, additional, El Benna, Naima, additional, Filali Maltouf, Abdelkarim, additional, Attaleb, Mohammed, additional, Chaoui, Imane, additional, Khyatti, Meriem, additional, and El Mzibri, Mohammed, additional

Published
2023
Full Text
View/download PDF

14. Immune checkpoints and telomerase: novel targetable axis in bladder cancer’s management

Author

Ahanidi Hajar, El, primary, EL AZZOUZI, Meryem, primary, HAFIDI ALAOUI, Chaimae, primary, Tetou, Tetou, primary, bensaid, Mounia, primary, chaoui, Imane, primary, BNBACER, Laila, primary, HASSAN, Ilias, primary, OUKABLI, Mohamed, primary, MICHAUD, Katarzyna, primary, AMEUR, Ahmed, primary, AL BOUZIDI, Abderrahmane, primary, EL MZIBRI, Mohammed, primary, JANDUS, Camilla, primary, and ATTALEB, Mohammed, primary

Published
2022
Full Text
View/download PDF

15. Leaf Extracts of Cistus ladanifer Exhibit Potent Antioxidant and Antiproliferative Activities against Liver, Prostate and Breast Cancer Cells

Author

Bouothmany, Kaoutar, primary, Bourhia, Mohammed, additional, Aoussar, Noura, additional, Attaleb, Mohammed, additional, Salamatullah, Ahmad, additional, Nafidi, Hiba-Allah, additional, Mellouki, Fouad, additional, El Mzibri, Mohammed, additional, Aboul-Soud, Mourad, additional, and Benbacer, Laila, additional

Published
2022
Full Text
View/download PDF

16. Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer

Author

El Ahanidi, Hajar, primary, El Azzouzi, Meryem, additional, Hafidi Alaoui, Chaimae, additional, Tetou, Mohammed, additional, Bensaid, Mounia, additional, Chaoui, Imane, additional, Benbacer, Laila, additional, Hassan, Ilias, additional, Oukabli, Mohamed, additional, Michaud, Katarzyna, additional, Ameur, Ahmed, additional, Al Bouzidi, Abderrahmane, additional, El Mzibri, Mohammed, additional, Jandus, Camilla, additional, and Attaleb, Mohammed, additional

Published
2022
Full Text
View/download PDF

17. Evaluation of TERT promoter mutations in tumor biopsies and urine sediment of Moroccan bladder cancer patients

Author

Hafidi Alaoui, Chaimae, primary, El Ahanidi, Hajar, additional, El Azzouzi, Meryem, additional, Filali-Maltouf, Abdelkarim, additional, Chaoui, Imane, additional, Bensaid, Mounia, additional, Benbacer, Laila, additional, Tetou, Mohammed, additional, Hassan, Ilias, additional, Oukabli, Mohamed, additional, Ameur, Ahmed, additional, Al Bouzidi, Abderrahmane, additional, Attaleb, Mohammed, additional, and El Mzibri, Mohammed, additional

Published
2022
Full Text
View/download PDF

18. Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer

Author

El Ahanidi, Hajar, El Azzouzi, Meryem, Hafidi Alaoui, Chaimae, Tetou, Mohammed, Bensaid, Mounia, Chaoui, Imane, Benbacer, Laila, Hassan, Ilias, Oukabli, Mohamed, Michaud, Katarzyna, Ameur, Ahmed, Al Bouzidi, Abderrahmane, El Mzibri, Mohammed, Jandus, Camilla, and Attaleb, Mohammed

Subjects
MicroRNAs, TERT, Bladder cancer, Immune checkpoint, Immunotherapy, ddc:616.07, bladder cancer, immune checkpoint, immunotherapy, microRNAs
Abstract

Tumor recurrence and progression in non-muscle invasive bladder cancer (NMIBC), therapy failure, and severe side effects in muscle invasive bladder cancer (MIBC) are the major challenges in the clinical management of bladder cancer (BC). Here, we identify new molecular targetable signatures to improve BC patients' stratification and the outcome of current immunotherapies. In a prospective cohort of 70 BC patients, we assessed the genetic and molecular regulation of TERT in maintaining telomere length in parallel to immune checkpoint and microRNA expression. TERT was undetectable in healthy bladder tissues but upregulated in invasive BC stages and high tumor grade. Its expression was linked with the combined effect of the C250T mutation and THOR hypermethylation, associated with progressing tumors and maintaining of telomere length. In the same cohort, PD-L1 scored highest in NMIBC, while PD-L2 was upregulated in MIBC. We also show that miR-100-5p and 138-5p were highly expressed in healthy bladder specimens and cell line, while expression decreased in the BC tissues and BC cell lines. In line with the binding prediction for these miRNAs on target genes, miRs 100-5p and 138-5p expression strongly inverse correlated with TERT, PD-L1, and PD-L2 expression, but not PD1. We identify a loop involving TERT, PD1-ligands, and miR-138-5p in BC, that might represent not only a useful biomarker for improved diagnosis and patients' stratification but also as a promising axis that might be therapeutically targetedin situ.

Published
2021

23. CHEK2 Germ Line Mutations are Lacking among Familial and Sporadic Breast Cancer Patients in Rwanda

Author

Habyarimana, Thierry, Attaleb, Mohammed, Mugenzi, Pacifique, Mazarati, Jean Baptiste, Bakri, Youssef, and Mzibri, Mohammed El

Subjects
Adult, Rwanda, Breast Neoplasms, Middle Aged, mutations, Prognosis, Checkpoint Kinase 2, Breast cancer, Case-Control Studies, Biomarkers, Tumor, Humans, Female, Genetic Predisposition to Disease, skin and connective tissue diseases, CHEK2, Germ-Line Mutation, Research Article, Follow-Up Studies
Abstract

Worldwide, breast cancer is the most frequent neoplasm and the second leading cause of cancer death among females. It dominates in both developed and developing countries and represents a major public health problem. The etiology is multifactorial and involves exogenous agents as well as endogenous factors. Although they account for only a small fraction of the breast cancer burden, mutations in the BRCA1 and BRCA2 genes are known to confer a high risk predisposition. Mutations in moderate/low-penetrance genes may also contribute to breast cancer risk. Previous studies have shown that mutations in the CHEK2 gene are involved in breast cancer susceptibility due to its impact on DNA repair processes and replication checkpoints. This study was conducted to evaluate the frequencies of three germline mutations in CHEK2 gene (c.1100delC, R145W and I157T) in breast cancers in Rwanda. Using direct DNA sequencing, we analyzed 41 breast cancer patients and 42 normal breast controls but could not detect any positives. CHEK2 mutations may be a rare event in Rwandan population and may only play a minor if an role in breast cancer predisposition among familial and sporadic cases.

Published
2018

26. AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients' biopsies and matched urine.

Author

El Ahanidi, Hajar, El Azzouzi, Meryem, Arrouchi, Housna, Alaoui, Chaimae Hafidi, Tetou, Mohammed, Bensaid, Mounia, Oukabli, Mohamed, Ameur, Ahmed, Al Bouzidi, Abderrahmane, El Mzibri, Mohammed, and Attaleb, Mohammed

Subjects
CANCER patients, BLADDER cancer, DNA, GENETIC mutation, URINE, CANCER genes
Abstract

Introduction: in cancer cells, activating mutations in PIK3CA and AKT1 genes, major players of PI3K-AKT-mTOR signalling pathway, are widely reported in many cancers and present attractive targets for the identification of new therapeutics and better cancer management. The present study was planned to evaluate the mutational status of PIK3CA and AKT1 genes in bladder cancer patients and to assess the association between these mutations and patients' clinico-pathological features. Methods: in this prospective study, bladder cancer biopsies and matched urine sediments samples were collected form 70 patients. Mutations were assessed by deoxyribonucleic acid (DNA) sequencing and correlation with clinico-pathological data was performed using SPSS software. Results: AKT1 alterations were poorly detected. Only one patient with pT1 stage and high-grade tumour carried the E17K mutation. In PIK3CA exon 9, 2 point mutations, E545K and Q546E, and a SNP (E547E) were reported, whereas in exon 20, 2 point mutations (L989V and H1047R) and 2 SNPs (I1022I and T1025T) were detected. PIK3CA mutations were mainly observed in early stages and high-grade tumours. Statistical analysis showed no significant association between the studied AKT1 and PIK3CA mutations and patients' clinico-pathological parameters (p > 0.05). Detection of these mutations in voided urine samples showed a high specificity (100%) for both genes and a moderate sensitivity: 100% for AKT1 and 66.7% for PIK3CA genes. Conclusion: this study shows clearly that mutations in AKT1 and PIK3CA are rare events and could not be considered as valuable biomarkers for bladder cancer management. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

27. ASSESSMENT OF MOLECULAR BIOMARKERS FOR BLADDER CANCER DIAGNOSIS, GRADING AND PROGNOSIS

Author

AHANIDI, Hajar, HAFIDI ALAOUI, Chaimae, BENSAID, Mounia, EL MZIBRI, Mohammed, AMEUR, Ahmed, ABBAR, Mohammed, AL BOUZIDI, Abderrahmane, and Mohammed ATTALEB, Mohammed ATTALEB

Subjects
bladder cancer, biomarker, Morocco, tumor stratification, molecular signature
Abstract

Worldwide, bladder cancer is a very significant public health problem, in terms of prevalence, mortality and management for individuals and their families. Bladder cancer is the fourth most commonly diagnosed cancer in men and one of the heaviest cancers in terms of cost. Although transurethral resection of the bladder followed by intravesical instillation of live attenuated Bacillus Calmette���Gu��rin (BCG) is considered as the gold standard for patients with intermediate and high risk, only a small portion of patient responds to the BCG-therapy. Bladder cancer management is faced by the therapy failure, great side effects and some difficulties in histological classification. Accordingly, growing interest is given to the use of genetic, epigenetic and immunologic biomarkers for molecular signature characterization and tumor stratification. In Morocco, great efforts have been made to contribute to the improvement of management of bladder cancer and many studies were made to evaluate some genetic and epigenetic biomarkers. Generated data is of a great interest for characterization of bladder cancer tumors in Morocco and could be used for better management of this disease., Frontiers in Science and Engineering, Vol 8, Supplment 2 (2019)

Published
2019
Full Text
View/download PDF

28. EVALUATION OF GPX1 PRO198LEU POLYMORPHISM, GSTP1 EXPRESSION AND GENE PROMOTER METHYLATION IN MOROCCAN PATIENTS WITH BLADDER CANCER

Author

HADAMI, Khaoula, DAKKA, Nadia, BENSAID, Mounia, AMEUR, Ahmed, CHAHDI, Hafsa, OUKABLI, Mohamed, AL BOUZIDI, Abderrahmane, ATTALEB, Mohammed, and EL MZIBRI, Mohammed

Subjects
bladder cancer, oxidative stress, gpx1 pro198leu, gstp1 expression, morocco, urologic and male genital diseases
Abstract

Bladder cancer (BC) is the third most common male malignancy in Morocco. The risk factors for developing BC are multiples including dietary conditions, environmental exposure and oxidative stress. Glutathione Peroxidase-1 (GPX1) and Glutathione S-Transferase Pi (GSTP1) are two key enzymes in cell detoxification process. GPX1 Pro198Leu polymorphism is associated with a decrease of enzyme activity and may contribute to BC susceptibility. Deregulated expression of GSTP1 enzyme was reported in various human tumors, also, epigenetic silencing of GSTP1 gene by aberrant promoter methylation has been shown to be involved in the molecular pathway for cancer development. In this study, we aimed to assess the presence of GPX1 Pro198Leu polymorphism and determine the expression status of GSTP1-in relation to its promoter methylation- in Moroccan population to evaluate their association with the risk of developing BC in Moroccan patients. Genotyping of GPX1 Pro198Leu polymorphism was carried out by Sanger sequencing. GSTP1 expression was assessed by immunohistochemistry, GSTP1 promoter methylation status was studied by Methylation Specifiq PCR method. No significant association between GPX1 Pro198Leu polymorphism and BC occurrence was found (Pro/Leu vs. Pro/Pro: p=0.425). For the analysis of Pro198Leu polymorphism and progression of BC, no association was observed neither for stages (Pro/Leu vs. Pro/Pro: p=0.500) nor grades (Pro/Leu vs. Pro/Pro: p=0.415). GSTP1 expression was strong in 23.33%, moderate in 60% and weak in 13.33% of BC cases. Variability of the expression does not correlate with high-grade cancer or invasive-stage (p��0.05). No GSTP1 promoter methylation was detected in all cases. Our results showed that GPX1 Pro198Leu polymorphism and GSTP1 expression are not closely associated with the risk of BC in our population, suggesting that the effect of these biomarkers on BC development might be a result of a combination with other genetic and epigenetic alterations and/or non-genetic variables such as diet and lifestyle factors., Frontiers in Science and Engineering, Vol 8, Supplment 2 (2019)

Published
2019
Full Text
View/download PDF

29. THE MOLECULAR BASIS OF VIRO-INDUCED CARCINOGENESIS

Author

EL MZIBRI, Mohammed, CHAOUI, Imane, KHYATTI, Meriem, and ATTALEB, Mohammed

Abstract

Cancer is the most emerging condition effecting millions of people globally and the leading cause of death. Worldwide, cancer is considered a great public health problem...., Frontiers in Science and Engineering, Vol 8, Supplment 2 (2019)

Published
2019
Full Text
View/download PDF

30. Human papillomavirus detection in moroccan patients with nasopharyngeal carcinoma

Author

Belghmi Khalid, Dardari R'kia, Mouttaki Tarik, Naji Fadwa, Kandil Mostafa, Attaleb Mohammed, Laantri Nadia, Benchakroun Nadia, El Mzibri Mohammed, and Khyatti Meriem

Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Infectious and parasitic diseases, RC109-216
Abstract

Abstract Background Nasopharyngeal carcinoma (NPC) is a malignant tumor which arises in surface epithelium of the posterior wall of the nasopharynx. There's is evidence that Epstein Barr virus (EBV) is associated to NPC development. However, many epidemiologic studies point to a connection between viral infections by the human papillomavirus (HPV) and NPC. Method Seventy Moroccan patients with NPC were screened for EBV and HPV. EBV detection was performed by PCR amplification of BZLF1 gene, encoding the ZEBRA (Z Epstein-Barr Virus Replication Activator) protein, and HPV infection was screened by PCR amplification with subsequent typing by hybridization with specific oligonucleotides for HPV types 16, 18, 31, 33, 35, 45 and 59. Results The age distribution of our patients revealed a bimodal pattern. Sixty two cases (88.9%) were classified as type 3 (undifferentiated carcinoma), 6 (8.6%) as type 2 (non keratinizing NPC) and only 2 (2.9%) cases were classified as type 1 (keratinizing NPC). EBV was detected in all NPC tumors, whereas HPV DNA was revealed in 34% of cases (24/70). Molecular analysis showed that 20.8% (5/24) were infected with HPV31, and the remaining were infected with other oncogenic types (i.e., HPV59, 16, 18, 33, 35 and 45). In addition, statistical analysis showed that there's no association between sex or age and HPV infection (P > 0.1). Conclusion Our data indicated that EBV is commonly associated with NPC in Moroccan patients and show for the first time that NPC tumours from Moroccan patients harbour high risk HPV genotypes.

Published
2011
Full Text
View/download PDF

31. Tomentosin Induces Telomere Shortening and Caspase-Dependant Apoptosis in Cervical Cancer Cells

Author

Merghoub, Nawel, El Btaouri, Hassan, Benbacer, Laila, Gmouh, Saïd, Trentesaux, Chantal, Brassart, Bertrand, Attaleb, Mohammed, Madoulet, Claudie, Wenner, Thomas, Amzazi, Saaïd, Morjani, Hamid, El Mzibri, Mohamed, Biology and Mediacl Research Unit, Centre National de l'Energie, des Sciences et Techniques Nucléaires, EA2063 - biochimie et biologie moléculaire, Université de Reims Champagne-Ardenne (URCA), Matrice extracellulaire et dynamique cellulaire - UMR 7369 (MEDyC), SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Centre National de la Recherche Scientifique (CNRS), Faculté des sciences [Rabat], Université Mohammed V de Rabat [Agdal], Centre National de l’Energie, des Sciences et des Techniques Nucléaires (CNE ), Volubilis AI n° MA/07/178 - Egide n° 13466WE, and 2007-2010, 'Comité Mixte Inter-universitaire Franco-Marocain'

Subjects
G2 Phase, Membrane Potential, Mitochondrial, TELOMERE SHORTENING, Caspase 3, Blotting, Western, Uterine Cervical Neoplasms, Cell Cycle Checkpoints, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Telomere, CERVICAL CANCER, APOPTOSIS, Lactones, TOMENTOSIN, Cell Line, Tumor, Humans, Female, CYTOTOXICITY, Reactive Oxygen Species, Sesquiterpenes, Cell Division, ComputingMilieux_MISCELLANEOUS, Cell Proliferation, HeLa Cells
Abstract

Tomentosin, a natural sesquiterpene lactone purified from of Inula viscosa L., was investigated for its anti-proliferative, telomere shortening, and apoptotic effects on human cervical cancer HeLa and SiHa cell lines. Tomentosin was found to inhibit the growth of SiHa and HeLa cell lines in dose and time-dependent manner (IC

Published
2017
Full Text
View/download PDF

34. BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso

Author

Zoure, Abdou Azaque, primary, Slaoui, Meriem, additional, Bambara, Hierrhum Aboubacar, additional, Sawadogo, Alexis Yobi, additional, Compaoré, Tegwendé Rebeca, additional, Ouédraogo, Nabonswindé Lamoussa Marie, additional, El Mzibri, Mohammed, additional, Attaleb, Mohammed, additional, Traoré, Si Simon, additional, Simpore, Jacques, additional, and Bakri, Youssef, additional

Published
2018
Full Text
View/download PDF

37. HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study

Author

Berraho, Mohamed, primary, Amarti-Riffi, Afaf, additional, El-Mzibri, Mohammed, additional, Bezad, Rachid, additional, Benjaafar, Noureddine, additional, Benideer, Abdelatif, additional, Matar, Noureddine, additional, Qmichou, Zinab, additional, Abda, Naima, additional, Attaleb, Mohammed, additional, Znati, Kaoutar, additional, El Fatemi, Hind, additional, Bendahhou, Karima, additional, Obtel, Majdouline, additional, Filali Adib, Abdelhai, additional, Mathoulin-Pelissier, Simone, additional, and Nejjari, Chakib, additional

Published
2017
Full Text
View/download PDF

38. Tomentosin Induces Telomere Shortening and Caspase-Dependant Apoptosis in Cervical Cancer Cells

Author

Merghoub, Nawel, primary, El Btaouri, Hassan, additional, Benbacer, Laila, additional, Gmouh, Saïd, additional, Trentesaux, Chantal, additional, Brassart, Bertrand, additional, Attaleb, Mohammed, additional, Madoulet, Claudie, additional, Wenner, Thomas, additional, Amzazi, Saaid, additional, Morjani, Hamid, additional, and El Mzibri, Mohamed, additional

Published
2016
Full Text
View/download PDF

41. Role of the Epstein-Barr Virus ZEBRA Protein and HPV in the Carcinogenesis of Nasopharyngeal Carcinoma

Author

Benider Abdellatif, Attaleb Mohammed, Laantri Nadia, Moumad Khalid, Ennaji Mustapha, Benchakroun Nadia, Khyatti Meriem, and Dardari R’kia

Subjects
stomatognathic diseases, Nasopharyngeal carcinoma, medicine, otorhinolaryngologic diseases, Biology, Carcinogenesis, medicine.disease_cause, medicine.disease, Zebra (medicine), Epstein–Barr virus, Virology
Abstract

Moumad Khalid1,4, Laantri Nadia1, Attaleb Mohammed2, Dardari R’kia1, Benider Abdellatif3, Benchakroun Nadia3, Ennaji Mustapha4 and Khyatti Meriem1 1Laboratory of Oncovirology, Institut Pasteur du Maroc, Casablanca, 2Biology and Medical Research Unit, Centre National de l’Energie, des Sciences et Techniques Nucleaires (CNESTEN), Rabat, 3Service de Radiotherapie, Centre d′Oncologie IBN Rochd, Casablanca, 4Laboratoire de Biologie Moleculaire, Institut Pasteur du Maroc, Casablanca Morocco

Published
2012

42. Inula ViscosaExtracts Induces Telomere Shortening and Apoptosis in Cancer Cells and Overcome Drug Resistance

Author

Merghoub, Nawal, primary, El Btaouri, Hassan, additional, Benbacer, Laila, additional, Gmouh, Saïd, additional, Trentesaux, Chantal, additional, Brassart, Bertrand, additional, Terryn, Christine, additional, Attaleb, Mohammed, additional, Madoulet, Claudie, additional, Benjouad, Abdelaziz, additional, Amzazi, Saaïd, additional, El Mzibri, Mohammed, additional, and Morjani, Hamid, additional

Published
2016
Full Text
View/download PDF

47. Human papillomavirus detection in Moroccan patients with bladder cancer

Author

Berrada, Noâma, primary, Al-Bouzidi, Abderrahmane, additional, Ameur, Ahmed, additional, Abbar, Mohammed, additional, El-Mzibri, Mohammed, additional, Ameziane-El-Hassani, Rabii, additional, Benbacer, Laïla, additional, Khyatti, Meriem, additional, Qmichou, Zineb, additional, Amzazi, Saaïd, additional, and Attaleb, Mohammed, additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results